Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-24T06:30:07.393Z Has data issue: false hasContentIssue false

Duration of apnoea with two different intubating doses of remifentanil

Published online by Cambridge University Press:  16 August 2006

A. Woods
Affiliation:
Department of Anaesthesia, Victoria Infirmary, Langside Road, Glasgow, UK
S. Grant
Affiliation:
Department of Anaesthesiology, Dukes Medical Center, Durham, North Carolina, USA
A. Davidson
Affiliation:
Department of Anaesthesia, Victoria Infirmary, Langside Road, Glasgow, UK
Get access

Abstract

We have studied the apnoea time after induction with two successful drug intubating regimes, both containing remifentanil. Group 1 (n=20); propofol 2 mg kg−1 and remifentanil 2 μg kg−1 and group 2 (n=20); propofol 2 mg kg−1, remifentanil 1 μg kg−1 and lignocaine 1 mg kg−1. Intubation was possible in all 40 patients, and regarded as acceptable in 90% and 85% of patients, respectively. The median time to the return of spontaneous respiration was 487 s in group 1 and 270 s in group 2 (P < 0.05). Median end-tidal CO2 concentration at the time of the first spontaneous respiration was 7.37 kPa in group 1 and 6.3 kPa in group 2 (P < 0.05). Both groups had a decrease in heart rate after induction, but this failed to reach either clinical or statistical significance, and no patient required atropine. Similarly, there was a decrease in arterial pressure after induction in both groups (P < 0.05), but this was not deemed to be clinically significant. Only two patients in each group required ephedrine 6 mg before arterial pressure was restored to within 25% of the base-line. Intubating conditions were similar in both groups, but group 2 provided a significantly shorter apnoea time.

Type
Original Article
Copyright
1999 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)